The point-of-care cholesterol monitoring devices market size was estimated to be worth US$ 428.8 million in 2021, and it is projected to increase to US$ 514.7 million by 2028. A new Future Market Insights study on the global sales scenario for point-of-care cholesterol monitoring devices projects just under 2.6% year-over-year revenue growth for the market …